Related Experiment Video
Updated: Jan 27, 2026

11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.5K
Summary
Shared decision-making (SDM) in pediatrics involves patients and providers discussing treatment options. This approach can reduce patient-provider conflict, build trust, and potentially lower healthcare costs.
Area of Science:
- Pediatric Healthcare Research
- Medical Ethics
- Patient Engagement Strategies
Background:
- Shared decision-making (SDM) is a collaborative approach to medical treatment choices.
- While extensively studied in adults, SDM in pediatric settings is an emerging area of research.
- Existing research highlights potential benefits like reduced decisional conflict and increased trust.
Purpose of the Study:
- To explore the unique characteristics of SDM within pediatric healthcare.
- To provide practical examples of SDM implementation in child health.
- To contribute to the growing body of knowledge on pediatric SDM.
Main Methods:
- Literature review focusing on SDM in pediatric contexts.
- Analysis of unique patient-provider dynamics in pediatrics.
- Case study examples illustrating SDM applications in child healthcare.
Main Results:
- SDM in pediatrics presents distinct considerations compared to adult care.
- Successful implementation requires tailored communication strategies for children and families.
- Examples demonstrate effective application across various pediatric scenarios.
Conclusions:
- SDM is a valuable framework for pediatric care, enhancing patient-centeredness.
- Further research is needed to fully understand and optimize SDM in pediatrics.
- Implementing SDM can improve patient outcomes and satisfaction in child health.
Related Concept Videos
Decision Making
944
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
Automatic decision-making is fast, intuitive, and relies on gut feelings...
944
Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Decision Making: P-value Method
6.9K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
6.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism
212
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
271
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271

